A61L 29/16
Biologically active materials
Official title: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
A61L29/16 (Biologically active materials) appears on 1,915 US grants and 2,859 published applications in this corpus.
Search patents in A61L- Granted patents
- 1,915
- Published applications
- 2,859
- Assignees
- 1,008
- Inventors
- 3,946
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 8 | 0 |
| 1987 | 7 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 11 | 0 |
| 1991 | 10 | 0 |
| 1992 | 6 | 0 |
| 1993 | 6 | 0 |
| 1994 | 21 | 0 |
| 1995 | 16 | 0 |
| 1996 | 23 | 0 |
| 1997 | 22 | 0 |
| 1998 | 32 | 0 |
| 1999 | 18 | 0 |
| 2000 | 20 | 0 |
| 2001 | 35 | 14 |
| 2002 | 32 | 49 |
| 2003 | 41 | 73 |
| 2004 | 29 | 88 |
| 2005 | 27 | 105 |
| 2006 | 23 | 87 |
| 2007 | 16 | 120 |
| 2008 | 29 | 139 |
| 2009 | 24 | 93 |
| 2010 | 53 | 164 |
| 2011 | 65 | 139 |
| 2012 | 90 | 120 |
| 2013 | 102 | 132 |
| 2014 | 114 | 148 |
| 2015 | 105 | 154 |
| 2016 | 84 | 144 |
| 2017 | 114 | 121 |
| 2018 | 96 | 125 |
| 2019 | 91 | 134 |
| 2020 | 97 | 142 |
| 2021 | 88 | 126 |
| 2022 | 74 | 107 |
| 2023 | 81 | 120 |
| 2024 | 85 | 95 |
| 2025 | 78 | 75 |
| 2026 | 28 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Synergistic activity of novel compounds against planktonic and biofilm cells of clinically relevant pathogens6 Oct 2026US 12,752,038 B2SterileCare Inc.
- Conformal, non-occluding sensor array for cardiac mapping and ablation22 Sep 2026US 12,741,063 B2Cornell University
- Tissue-plasminogen activator coated catheter with hydrogel-controlled elution8 Sep 2026US 12,728,185 B2Becton, Dickinson and Company
- Robust nitric oxide-releasing polymers and articles and methods of making and uses thereof1 Sep 2026US 12,721,935 B2University of Georgia Research Foundation, Inc.
- Drug coated balloon1 Sep 2026US 12,721,977 B2Medtronic Vascular, Inc.
- Trodusquemine-coated balloon for targeted treatment of atherosclerosis8 Oct 2026US 2026/0306719 A1Bard Peripheral Vascular, Inc.
- Method for treatment of airway stricture or stenosis8 Oct 2026US 2026/0306805 A1Airiver Medical, Inc.
- Nanogel comprising bioactive molecules, therapeutic molecules or drugs together with an amphiphilic molecule24 Sep 2026US 2026/0284275 A1
- Collagen peptide-based medicament compositions and devices and methods of production and use thereof17 Sep 2026US 2026/0273015 A1Sustain Holdings, LLC
- Bacteriophage cocktail-containing hydrogel compositions and methods of production and use thereof17 Sep 2026US 2026/0273143 A1
Most cited
By later US patents
- Dilating and support apparatus with disease inhibitors and methods for use1,862US 6,450,989 B2Artemis Medical, Inc. · 2002
- Coated implantable medical device1,180US 6,096,070 ACook Incorporated · 2000
- Coated implantable medical device1,071US 5,824,049 AMED Institute, Inc. · 1998
- Silver implantable medical device1,026US 5,873,904 ACook Incorporated · 1999
- Coated implantable medical device1,014US 6,299,604 B1Cook Incorporated · 2001